Paris, France

Xavier Jacq



Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Etuz, FR (2011)
  • Paris, FR (2008 - 2014)

Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Xavier Jacq: Innovator in Therapeutic Applications

Introduction

Xavier Jacq is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic applications, particularly through his innovative work on cysteine protease inhibitors. With a total of 3 patents to his name, Jacq continues to push the boundaries of medical science.

Latest Patents

Jacq's latest patents include groundbreaking inventions such as "Cysteine protease inhibitors and their therapeutic applications." This invention concerns new compounds of formula (I), their process of preparation, and their therapeutic use. Another notable patent is "Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications." This patent also focuses on new compounds of formula (I) and outlines their preparation and therapeutic applications, detailing specific components as defined in the claims.

Career Highlights

Xavier Jacq has established himself as a key figure in the pharmaceutical industry. He works at Hybrigenics S.A., a company known for its innovative approaches to drug development. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options in medicine.

Collaborations

Throughout his career, Jacq has collaborated with notable professionals in his field, including Philippe Guedat and Frédéric Colland. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Xavier Jacq's contributions to the field of therapeutic applications through his patents demonstrate his commitment to innovation and medical advancement. His work continues to inspire future research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…